These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6423093)

  • 1. Treatment of hypercalcaemia associated with malignancy.
    Wilkinson R
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):812-3. PubMed ID: 6423093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone physiology. Hypercalcaemia of malignancy.
    Meikle MC
    Nature; 1988 Nov; 336(6197):311. PubMed ID: 3194015
    [No Abstract]   [Full Text] [Related]  

  • 5. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypercalcemia of malignancy with bisphosphonates.
    Berenson JR
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):12-8. PubMed ID: 12584690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of early diagnosis of cancer-related hypercalcaemia].
    Radványi I; Csikós A; Balogh S
    Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcaemia of malignancy.
    Perez DJ
    N Z Med J; 1993 Aug; 106(961):341-3. PubMed ID: 8341477
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercalcaemia and malignancy.
    Heath DA
    Ann Clin Biochem; 1976 Nov; 13(6):555-60. PubMed ID: 1015787
    [No Abstract]   [Full Text] [Related]  

  • 11. Inorganic phosphate for hypercalcaemia of malignancy.
    Scolding NJ
    Lancet; 1985 Dec; 2(8467):1299. PubMed ID: 2866355
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of diphosphonates in hypercalcaemia due to neoplasia.
    Kanis JA; Percival RC; Yates AJ; Urwin GH; Hamdy NA
    Lancet; 1986 Mar; 1(8481):615-6. PubMed ID: 2869324
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis.
    Heyburn PJ; Child JA; Peacock M
    J Clin Pathol; 1981 Jan; 34(1):54-7. PubMed ID: 6450779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer hypercalcemia: recent advances in understanding and treatment.
    Body JJ
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):865-9. PubMed ID: 6378642
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
    Aasarød K; Lamvik J
    Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1293-6. PubMed ID: 2734758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignancy-associated hypercalcemia with norethisterone: a case report.
    Anderson CS; Olweny CL; Need AG
    Aust N Z J Med; 1989 Feb; 19(1):51-4. PubMed ID: 2764805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy.
    Bower M; Stein RC; Hedley A; Davenport J; Colston K; Coombes RC
    Cancer Chemother Pharmacol; 1991; 28(4):311-2. PubMed ID: 1879049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.